O24.93 Unspecified diabetes mellitus in the puerperium

Name of the Condition

• Unspecified diabetes mellitus in the puerperium (O24.93)

Summary

This condition refers to diabetes mellitus that occurs or is first recognized during the puerperium (postpartum period) without specification of the diabetes type. It may include pregestational diabetes (existing before pregnancy) or gestational diabetes (onset during pregnancy) that persists or is diagnosed after delivery. The unspecified nature indicates that the specific type of diabetes was not documented or differentiated at the time of diagnosis.

Causes

Diabetes in the puerperium can result from preexisting type 1 or type 2 diabetes (pregestational) or develop due to hormonal changes that impair insulin sensitivity during pregnancy (gestational). Insulin resistance may persist or become apparent after delivery, particularly if glucose metabolism was not fully evaluated during pregnancy. The unspecified designation may reflect incomplete documentation or lack of further classification at the time of diagnosis.

Risk Factors

• Preexisting type 1 or type 2 diabetes.
• Family history of diabetes.
• Obesity (BMI ≥30).
• Advanced maternal age (≥35 years).
• Previous gestational diabetes.
• Polycystic ovary syndrome (PCOS).
• Ethnicity (higher prevalence in certain groups, e.g., Hispanic, African American, Asian).
• History of large-for-gestational-age infants or unexplained stillbirth.

Symptoms

• Increased thirst and urination.
• Fatigue.
• Blurred vision.
• Recurrent infections (e.g., yeast infections).
• Nausea or vomiting (may overlap with postpartum symptoms).
• Unexplained weight loss or gain.

Diagnosis

Diagnosis involves evaluating blood glucose levels during the postpartum period. Tests may include fasting plasma glucose, oral glucose tolerance test (OGTT), or hemoglobin A1c (HbA1c). The unspecified nature of the code means the specific type of diabetes (type 1, type 2, or gestational) was not documented at the time of diagnosis. Further testing may be required to differentiate the type if clinically indicated.

Treatment Options

Management focuses on glycemic control through diet, exercise, and medication (e.g., insulin or oral hypoglycemics). Postpartum follow-up is critical to assess whether diabetes persists or resolves. Breastfeeding considerations and medication safety in lactation should be addressed.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and management. Gestational diabetes often resolves postpartum, but some individuals may develop type 2 diabetes later. Regular follow-up, including glucose monitoring and lifestyle counseling, is recommended to reduce long-term risks.

Complications

• Persistent hyperglycemia leading to type 2 diabetes.
• Increased risk of cardiovascular disease.
• Recurrent gestational diabetes in future pregnancies.
• Delayed wound healing or infection.

Lifestyle & Prevention

• Maintain a balanced diet and regular physical activity.
• Monitor blood glucose levels as advised.
• Attend postpartum follow-up appointments.
• Avoid smoking and limit alcohol intake.

When to Seek Professional Help

Seek care if experiencing symptoms of hyperglycemia (e.g., excessive thirst, frequent urination) or if blood glucose levels are consistently elevated. Prompt evaluation is important to prevent complications.

Tips for Medical Coders

Document the timing of diagnosis (puerperium) and any available details about the diabetes type. If the type is unspecified, use this code. Ensure documentation supports the postpartum context and absence of further classification.